iTakeControl Health Joins Red Nucleus
iTakeControl video, virtual trial, and ePRO products and services expands Red Nucleus into clinical research space.
News provided by
Share this article
Share this article
BOSTON, March 4, 2021 /PRNewswire/ iTakeControl (ITC), a leading provider of clinical operations and medical affairs technology and services focused on rare disease and specialty pharma, announces that it has been acquired by Red Nucleus, a premier provider of learning, performance, and process solutions for the life sciences industry.
With its track record of excellence, geographic reach, and resources, Red Nucleus accelerates ITC s ability to scale its offerings in the use of video to collect clinical data, conduct remote clinical research visits between physicians and patients, and innovate the use of mobile platforms for learning and development and patient engagement to support long-term follow up.